Four Ways AI Is Changing Market Access for the Better
Authored by Ellen Cappellino, Ryan Slipakoff
Authors
Ellen Cappellino
Executive Director, Value Access, and Reimbursement
Ellen Cappellino has 25+ years in the biopharmaceutical industry, specializing in market access and product launches, notably in oncology and rare diseases. Her experience spans leadership roles at AstraZeneca, Vertex Pharmaceuticals, and Pfizer, and a foundational role as a research pharmacist at Wyeth Pharmaceuticals. Ellen, an alumnus of Albany College of Pharmacy and Health Sciences and New York University (MBA), now serves as Executive Director of Value, Access, and Reimbursement at Klick, focusing on optimizing therapy placement.
Ryan Slipakoff
Chief Transformation Officer
Ryan is Klick's Chief Transformation Officer, driving innovation, new product development, and accelerating and augmenting Klick’s digital transformation practice. Ryan is an executive partner and sponsor for our clients as they seek to accelerate their commercial maturity, create competitive advantage, and tackle healthcare’s most complex challenges. Ryan is a holistic customer experience expert, blending expertise across strategy, technology, digital, analytics, operations, and data into harmonized solutions and offerings.
Ready to Drive Life Sciences Forward?
Experience the transformative power of Klick Health, where deep industry expertise meets cutting-edge AI-driven wisdom.
As your trusted partners in life sciences commercialization, we combine a storied history in healthcare with the latest technologies to elevate every facet of your omnichannel strategy. From crafting engaging narratives to enabling data-driven decision-making, our integrated capabilities ensure you lead the way in transforming patient outcomes through digital health innovation.
Let’s create something transformative together.
